title: Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules. Department of Urogynaecology, King's College Hospital, London.
authors.affiliation: Department of Urogynaecology, King's College Hospital, London.
authors.forename: J C
authors.initials: JC
authors.lastname: Stevenson
authors.forename: U
authors.initials: U
authors.lastname: Gaspard
authors.forename: B
authors.initials: B
authors.lastname: Avouac
authors.forename: C
authors.initials: C
authors.lastname: Bricaire
authors.forename: L
authors.initials: L
authors.lastname: Cardozo
authors.forename: P
authors.initials: P
authors.lastname: Collins
authors.forename: J P
authors.initials: JP
authors.lastname: Devogelaer
authors.forename: M
authors.initials: M
authors.lastname: Dören
authors.forename: C
authors.initials: C
authors.lastname: Gennari
authors.forename: J M
authors.initials: JM
authors.lastname: Kaufman
authors.forename: F
authors.initials: F
authors.lastname: Kuttenn
authors.forename: J D
authors.initials: JD
authors.lastname: Ringe
authors.forename: C
authors.initials: C
authors.lastname: Scarafiotti
authors.forename: L
authors.initials: L
authors.lastname: Vanhaelst
authors.forename: L
authors.initials: L
authors.lastname: Zichella
authors.forename: R
authors.initials: R
authors.lastname: Ziegler
authors.forename: J Y
authors.initials: JY
authors.lastname: Reginster
mesh_terms: D003327:Coronary Disease / Q000517:prevention & control; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005831:Genital Diseases, Female / Q000517:prevention & control; D006801:Humans; D011788:Quality of Life; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage / Q000627:therapeutic use*; D014570:Urologic Diseases / Q000517:prevention & control
chemical_list: D004967:Estrogens; D020845:Selective Estrogen Receptor Modulators